SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12.18 |
| Enterprise Value ($M) | 6.31 |
| Book Value ($M) | 4.24 |
| Book Value / Share | 0.29 |
| Price / Book | 2.87 |
| NCAV ($M) | 2.54 |
| NCAV / Share | 0.17 |
| Price / NCAV | 4.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.46 |
| Return on Assets (ROA) | -1.30 |
| Return on Equity (ROE) | -2.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.67 |
| Current Ratio | 1.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.01 |
| Assets | 9.72 |
| Liabilities | 5.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -19.13 |
| Net Income | -18.62 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.85 |
| Cash from Investing | 9.83 |
| Cash from Financing | 9.06 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ayrton Capital LLC | 7.90 | ||
| 13G/A | CVI Investments, Inc. | 4.90 | -37.57 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 31,120 | 76,868 | 40.48 | |
| 27,461 | 83,383 | 32.93 | |
| 13,640 | 47,112 | 28.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMCC – IM Cannabis Corp. | IMMX – Immix Biopharma, Inc. |
| IMNM – Immunome, Inc. | IMTX – Immatics N.V. |
| INAB – IN8bio, Inc. |
Financial data and stock pages provided by
Fintel.io